Rhythm Pharmaceuticals Inc. (RYTM)

Finanzdaten der Rhythm Pharmaceuticals Inc.-Aktie (RYTM)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.69% 24.23	22.50	19.22	11.47	8.79
Cost Of Revenue	34.04% 3.233	2.412	2.236	1.421	1.028
Gross Profit	4.52% 21.00	20.09	16.98	10.05	7.762
Operating Expenses	2.78% 62.27	64.05	63.59	62.58	49.87
Interest Income/Expense	44.49% 4.55	3.149	3.303	3.061	3.011
Benefits Costs and Expenses	0.95% 65.67	66.30	65.83	63.65	51.28
Costs And Expenses	1.44% 65.50	66.46	65.83	64.00	50.89
Operating Income/Loss	6.12% -41.27	-43.95	-46.60	-52.53	-42.10
Nonoperating Income/Loss	208.86% -0.172	0.158	-0.099	0.352	-0.39
Income/Loss From Continuing Operations Before Tax	5.38% -41.44	-43.80	-46.70	-52.18	-42.49
Income Tax Expense/Benefit	46.74% 0.196	0.368	-	-	-
Income/Loss From Continuing Operations After Tax	5.73% -41.63	-44.16	-46.70	-52.18	-42.49
Net Income/Loss	5.73% -41.63	-44.16	-46.70	-52.18	-42.49
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.10% 0.5183	57.87	56.87	56.71	1.4082
Diluted Average Shares	99.10% 0.5183	57.87	56.87	56.71	1.4082
Basic Earnings Per Share	7.89% -0.70	-0.76	-0.82	-0.92	-0.74
Diluted Earnings Per Share	7.89% -0.70	-0.76	-0.82	-0.92	-0.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-